Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis.
Ann Hematol
; 101(9): 2001-2010, 2022 Sep.
Article
in En
| MEDLINE
| ID: mdl-35739428
Full text:
1
Database:
MEDLINE
Main subject:
Pyrazines
/
Leukemia, Myeloid, Acute
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Ann Hematol
Journal subject:
HEMATOLOGIA
Year:
2022
Type:
Article
Affiliation country:
Israel